- call +1-201-465-4211
- email sales@mrinsights.biz
Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration.PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel.
Scope of the Report:
This report studies the Platelet Rich Plasma market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Platelet Rich Plasma market by product type and applications/end industries.
The global Platelet Rich Plasma market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Platelet Rich Plasma.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AdiStem Ltd.
Arthrex, Inc.
Biomet, Inc.
Cesca Therapeutics, Inc.
DePuy Synthes, Inc.
EmCyte Corporation
Exactech, Inc.
Harvest Technologies Corp.
Nuo Therapeutics, Inc.
Regen Lab SA
Stryker Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pure PRP
Leukocyte-Rich PRP
Leukocyte-Rich Fibrin
Market Segment by Applications, can be divided into
Orthopedics
Cosmetic Surgery & Dermatology
Ophthalmic Surgery
Neurosurgery
General surgery
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Platelet Rich Plasma Market Overview
1.1 Product Overview and Scope of Platelet Rich Plasma
1.2 Classification of Platelet Rich Plasma by Types
1.2.1 Global Platelet Rich Plasma Revenue Comparison by Types (2017-2023)
1.2.2 Global Platelet Rich Plasma Revenue Market Share by Types in 2017
1.2.3 Pure PRP
1.2.4 Leukocyte-Rich PRP
1.2.5 Leukocyte-Rich Fibrin
1.3 Global Platelet Rich Plasma Market by Application
1.3.1 Global Platelet Rich Plasma Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Orthopedics
1.3.3 Cosmetic Surgery & Dermatology
1.3.4 Ophthalmic Surgery
1.3.5 Neurosurgery
1.3.6 General surgery
1.3.7 Others
1.4 Global Platelet Rich Plasma Market by Regions
1.4.1 Global Platelet Rich Plasma Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Platelet Rich Plasma Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Platelet Rich Plasma Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Platelet Rich Plasma Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Platelet Rich Plasma Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Platelet Rich Plasma Status and Prospect (2013-2023)
1.5 Global Market Size of Platelet Rich Plasma (2013-2023)
2 Manufacturers Profiles
2.1 AdiStem Ltd.
2.1.1 Business Overview
2.1.2 Platelet Rich Plasma Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AdiStem Ltd. Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.2 Arthrex, Inc.
2.2.1 Business Overview
2.2.2 Platelet Rich Plasma Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Arthrex, Inc. Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biomet, Inc.
2.3.1 Business Overview
2.3.2 Platelet Rich Plasma Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biomet, Inc. Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cesca Therapeutics, Inc.
2.4.1 Business Overview
2.4.2 Platelet Rich Plasma Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cesca Therapeutics, Inc. Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.5 DePuy Synthes, Inc.
2.5.1 Business Overview
2.5.2 Platelet Rich Plasma Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 DePuy Synthes, Inc. Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.6 EmCyte Corporation
2.6.1 Business Overview
2.6.2 Platelet Rich Plasma Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 EmCyte Corporation Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.7 Exactech, Inc.
2.7.1 Business Overview
2.7.2 Platelet Rich Plasma Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Exactech, Inc. Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.8 Harvest Technologies Corp.
2.8.1 Business Overview
2.8.2 Platelet Rich Plasma Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Harvest Technologies Corp. Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nuo Therapeutics, Inc.
2.9.1 Business Overview
2.9.2 Platelet Rich Plasma Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nuo Therapeutics, Inc. Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.10 Regen Lab SA
2.10.1 Business Overview
2.10.2 Platelet Rich Plasma Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Regen Lab SA Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
2.11 Stryker Corporation
2.11.1 Business Overview
2.11.2 Platelet Rich Plasma Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Stryker Corporation Platelet Rich Plasma Revenue, Gross Margin and Market Share (2016-2017)
3 Global Platelet Rich Plasma Market Competition, by Players
3.1 Global Platelet Rich Plasma Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Platelet Rich Plasma Players Market Share
3.2.2 Top 10 Platelet Rich Plasma Players Market Share
3.3 Market Competition Trend
4 Global Platelet Rich Plasma Market Size by Regions
4.1 Global Platelet Rich Plasma Revenue and Market Share by Regions
4.2 North America Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
4.3 Europe Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
4.5 South America Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
5 North America Platelet Rich Plasma Revenue by Countries
5.1 North America Platelet Rich Plasma Revenue by Countries (2013-2018)
5.2 USA Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
5.3 Canada Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
5.4 Mexico Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
6 Europe Platelet Rich Plasma Revenue by Countries
6.1 Europe Platelet Rich Plasma Revenue by Countries (2013-2018)
6.2 Germany Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
6.3 UK Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
6.4 France Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
6.5 Russia Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
6.6 Italy Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Platelet Rich Plasma Revenue by Countries
7.1 Asia-Pacific Platelet Rich Plasma Revenue by Countries (2013-2018)
7.2 China Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
7.3 Japan Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
7.4 Korea Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
7.5 India Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
8 South America Platelet Rich Plasma Revenue by Countries
8.1 South America Platelet Rich Plasma Revenue by Countries (2013-2018)
8.2 Brazil Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
8.3 Argentina Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
8.4 Colombia Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Platelet Rich Plasma by Countries
9.1 Middle East and Africa Platelet Rich Plasma Revenue by Countries (2013-2018)
9.2 Saudi Arabia Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
9.3 UAE Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
9.4 Egypt Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
9.5 Nigeria Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
9.6 South Africa Platelet Rich Plasma Revenue and Growth Rate (2013-2018)
10 Global Platelet Rich Plasma Market Segment by Type
10.1 Global Platelet Rich Plasma Revenue and Market Share by Type (2013-2018)
10.2 Global Platelet Rich Plasma Market Forecast by Type (2018-2023)
10.3 Pure PRP Revenue Growth Rate (2013-2023)
10.4 Leukocyte-Rich PRP Revenue Growth Rate (2013-2023)
10.5 Leukocyte-Rich Fibrin Revenue Growth Rate (2013-2023)
11 Global Platelet Rich Plasma Market Segment by Application
11.1 Global Platelet Rich Plasma Revenue Market Share by Application (2013-2018)
11.2 Platelet Rich Plasma Market Forecast by Application (2018-2023)
11.3 Orthopedics Revenue Growth (2013-2018)
11.4 Cosmetic Surgery & Dermatology Revenue Growth (2013-2018)
11.5 Ophthalmic Surgery Revenue Growth (2013-2018)
11.6 Neurosurgery Revenue Growth (2013-2018)
11.7 General surgery Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)
12 Global Platelet Rich Plasma Market Size Forecast (2018-2023)
12.1 Global Platelet Rich Plasma Market Size Forecast (2018-2023)
12.2 Global Platelet Rich Plasma Market Forecast by Regions (2018-2023)
12.3 North America Platelet Rich Plasma Revenue Market Forecast (2018-2023)
12.4 Europe Platelet Rich Plasma Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Platelet Rich Plasma Revenue Market Forecast (2018-2023)
12.6 South America Platelet Rich Plasma Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Platelet Rich Plasma Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Platelet Rich Plasma Picture
Table Product Specifications of Platelet Rich Plasma
Table Global Platelet Rich Plasma and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
